Cass County Medical Care Facil | |
23770 Hospital St, Cassopolis, Michigan 49031 | |
(269) 228-4000 | |
Name | Cass County Medical Care Facil |
---|---|
Location | 23770 Hospital St, Cassopolis, Michigan |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 80 |
Occupancy Rate | 74.5% |
Medicare ID (CCN) | 235352 |
Legal Business Name | County Of Cass |
Ownership Type | Government - County |
NPI Number | 1629064332 |
Organization Name | COUNTY OF CASS |
Doing Business As | CASS COUNTY MEDICAL CARE FACILITY |
Address | 23770 Hospital St, Cassopolis, MI 49031 |
Phone Number | 269-445-3801 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
Across the U.S. the esports athlete is a rising class of competitor in the highest collegiate and professional arenas. According to researchers in The Journal of the American Osteopathic Association, the field of sports medicine needs to catch up in order to address these players' particular needs.
In an Australian first, scientists at Sydney's Centenary Institute have mapped the anatomy of a membrane protein. This exciting discovery has the potential to turn the way we discover new drugs on its head and reduce the development time for new treatments.
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme (ACE) inhibitor proven effective in improving survival following heart attacks.
› Verified 6 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
Across the U.S. the esports athlete is a rising class of competitor in the highest collegiate and professional arenas. According to researchers in The Journal of the American Osteopathic Association, the field of sports medicine needs to catch up in order to address these players' particular needs.
In an Australian first, scientists at Sydney's Centenary Institute have mapped the anatomy of a membrane protein. This exciting discovery has the potential to turn the way we discover new drugs on its head and reduce the development time for new treatments.
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme (ACE) inhibitor proven effective in improving survival following heart attacks.
› Verified 6 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $16250 |
Number of Payment Denials | 1 |
Total Number of Penalties | 2 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.43 | 14.46 |
Percentage of long-stay residents who lose too much weight | 10.84 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 44.23 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 5.83 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.36 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 1.36 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.55 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 4.78 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 93.5 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.74 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 27.66 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 22.48 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 4.88 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.59 | 95.98 |
Percentage of short-stay residents who made improvements in function | 65.04 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.35 | 82.93 |
News Archive
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.
Across the U.S. the esports athlete is a rising class of competitor in the highest collegiate and professional arenas. According to researchers in The Journal of the American Osteopathic Association, the field of sports medicine needs to catch up in order to address these players' particular needs.
In an Australian first, scientists at Sydney's Centenary Institute have mapped the anatomy of a membrane protein. This exciting discovery has the potential to turn the way we discover new drugs on its head and reduce the development time for new treatments.
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme (ACE) inhibitor proven effective in improving survival following heart attacks.
› Verified 6 days ago
Cass County Medical Care Facil Location: 23770 Hospital St, Cassopolis, Michigan 49031 Phone: (269) 228-4000 |